Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(11):2029–37.
Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med. 2019;21(11):2413–21.
Article PubMed PubMed Central Google Scholar
Costain G, Walker S, Marano M, Veenma D, Snell M, Curtis M, et al. Genome sequencing as a diagnostic test in Children with Unexplained Medical Complexity. JAMA Netw Open. 2020;3(9):e2018109.
Article PubMed PubMed Central Google Scholar
Oei K, Hayeems RZ, Ungar WJ, Cohn RD, Cohen E. Genetic testing among children in a Complex Care Program. Child Basel Switz. 2017;4(5):42.
Lee PH, Feng YCA, Smoller JW. Pleiotropy and Cross-disorder Genetics among Psychiatric disorders. Biol Psychiatry. 2021;89(1):20–31.
Article CAS PubMed Google Scholar
Watanabe K, Stringer S, Frei O, Umićević Mirkov M, de Leeuw C, Polderman TJC, et al. A global overview of pleiotropy and genetic architecture in complex traits. Nat Genet. 2019;51(9):1339–48.
Article CAS PubMed Google Scholar
Negi SK, Guda C. Global gene expression profiling of healthy human brain and its application in studying neurological disorders. Sci Rep. 2017;7(1):897.
Article PubMed PubMed Central Google Scholar
Jacquemont S, Huguet G, Klein M, Chawner SJRA, Donald KA, van den Bree MBM, et al. Genes to Mental Health (G2MH): a Framework to Map the Combined effects of Rare and Common variants on dimensions of Cognition and Psychopathology. Am J Psychiatry. 2022;179(3):189–203.
Article PubMed PubMed Central Google Scholar
Keating CT, Hickman L, Leung J, Monk R, Montgomery A, Heath H, et al. Autism-related language preferences of English-speaking individuals across the globe: a mixed methods investigation. Autism Res off J Int Soc Autism Res. 2023;16(2):406–28.
Carter MT, Scherer SW. Autism spectrum disorder in the genetics clinic: a review. Clin Genet. 2013;83(5):399–407.
Article CAS PubMed Google Scholar
van Karnebeek C, Murphy T, Giannasi W, Thomas M, Connolly M, Stockler-Ipsiroglu S. Diagnostic value of a multidisciplinary clinic for intellectual disability. Can J Neurol Sci J Can Sci Neurol. 2014;41(3):333–45.
Fernandez BA, Scherer SW. Syndromic autism spectrum disorders: moving from a clinically defined to a molecularly defined approach. Dialogues Clin Neurosci. 2017;19(4):353–71.
Article PubMed PubMed Central Google Scholar
Savatt JM, Myers SM. Genetic testing in Neurodevelopmental disorders. Front Pediatr. 2021;9:526779.
Article PubMed PubMed Central Google Scholar
Vorstman JAS, Parr JR, Moreno-De-Luca D, Anney RJL, Nurnberger JI, Hallmayer JF. Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet. 2017;18(6):362–76.
Article CAS PubMed Google Scholar
Vermeulen K, Staal WG, Janzing JG, van Bokhoven H, Egger JIM, Kleefstra T. Sleep disturbance as a precursor of severe regression in Kleefstra Syndrome suggests a need for firm and Rapid Pharmacological Treatment. Clin Neuropharmacol. 2017;40(4):185–8.
Butcher NJ, Fung WLA, Fitzpatrick L, Guna A, Andrade DM, Lang AE, et al. Response to clozapine in a clinically identifiable subtype of schizophrenia. Br J Psychiatry J Ment Sci. 2015;206(6):484–91.
Baribeau D, Anagnostou E. Novel treatments for autism spectrum disorder based on genomics and systems biology. Pharmacol Ther. 2022;230:107939.
Article CAS PubMed Google Scholar
Baribeau D, Vorstman J, Anagnostou E. Novel treatments in autism spectrum disorder. Curr Opin Psychiatry. 2022;35(2):101–10.
Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, et al. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism. 2022;13(1):10.
Article CAS PubMed PubMed Central Google Scholar
Kolevzon A, Breen MS, Siper PM, Halpern D, Frank Y, Rieger H, et al. Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome. Mol Autism. 2022;13(1):17.
Article CAS PubMed PubMed Central Google Scholar
O’Leary HM, Kaufmann WE, Barnes KV, Rakesh K, Kapur K, Tarquinio DC, et al. Placebo-controlled crossover assessment of mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol. 2018;5(3):323–32.
Article PubMed PubMed Central Google Scholar
Overwater IE, Rietman AB, Mous SE, Bindels-de Heus K, Rizopoulos D, Ten Hoopen LW, et al. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. 2019;93(2):e200–9.
Srivastava S, Jo B, Zhang B, Frazier T, Gallagher AS, Peck F, et al. A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome. Hum Mol Genet. 2022;31(20):3393–404.
Article CAS PubMed PubMed Central Google Scholar
Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, et al. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med. 2012;4(152):152ra127.
Dindot SV, Christian S, Murphy WJ, Berent A, Panagoulias J, Schlafer A, et al. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript. Sci Transl Med. 2023;15(688):eabf4077.
Article CAS PubMed Google Scholar
Hong D, Iakoucheva LM. Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology. Transl Psychiatry. 2023;13(1):58.
Article CAS PubMed PubMed Central Google Scholar
Óskarsdóttir S, Boot E, Crowley TB, Loo JCY, Arganbright JM, Armando M, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med off J Am Coll Med Genet. 2023;25(3):100338.
Morris CA, Braddock SR, COUNCIL ON GENETICS. Health Care Supervision for Children with Williams Syndrome. Pediatrics. 2020;145(2):e20193761.
Duis J, van Wattum PJ, Scheimann A, Salehi P, Brokamp E, Fairbrother L, et al. A multidisciplinary approach to the clinical management of Prader-Willi syndrome. Mol Genet Genomic Med. 2019;7(3):e514.
Article PubMed PubMed Central Google Scholar
Hersh JH, Saul RA. Committee on Genetics. Health Supervision for Children with Fragile X Syndrome. Pediatrics. 2011;127(5):994–1006.
de Vries PJ, Heunis TM, Vanclooster S, Chambers N, Bissell S, Byars AW, et al. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND). J Neurodev Disord. 2023;15(1):32.
Article PubMed PubMed Central Google Scholar
Mefford HC. Genotype to phenotype-discovery and characterization of novel genomic disorders in a genotype-first era. Genet Med off J Am Coll Med Genet. 2009;11(12):836–42.
Pujol P, Barberis M, Beer P, Friedman E, Piulats JM, Capoluongo ED, et al. Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. Eur J Cancer Oxf Engl 1990. 2021;146:30–47.
Comments (0)